Search results with tag "For the treatment"
Evidence-Based Treatment for Opioid Use Disorder Evidence ...
www.apa.orgfor the treatment of co-occurring disorders (e.g., anxiety, depression) in . people with opioid use disorder, behavioral therapy is a promising strategy for addressing these conditions. REFERENCES. Connery, H.S. (2015). Medication-assisted treatment for opioid use . disorder: Review of the evidence and future directions. Harvard Review of ...
Guideline on the clinical development of medicinal ...
www.ema.europa.euGuideline on the clinical development of medicinal products intended for the treatment of pain EMA/CHMP/970057/2011 Page 4/29 1. Executive summary This Guideline is intended to provide guidance on the clinical development of new medicinal products for the treatment of pain. It replaces and updates the separate guidelines on neuropathic
PRACTICE GUIDELINE FOR THE Treatment of Patients With ...
psychiatryonline.orgSteering Committee on Practice Guidelines also reviewed this guideline and found no evidence of influence from these relationships. The development process for this guideline, including the roles of the Work Group, Inde-pendent Review Panel, Steering Committee, APA Assem-bly, and APA Board of Trustees is described in “Overview
“Michigan Guidelines for the Use of Controlled Substances ...
www.michigan.gov“Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain” Effective April 1, 1999, the Pain and Symptom Management Advisory Committee was
containing chemotherapy. (1.6) neoadjuvant or adjuvant ...
www.merck.comas a single agent for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy whose tumors express PD-L1 (CPS ≥1) as determined by an FDA-approved test. (1.11, 2.1) Hepatocellular Carcinoma (HCC) for the treatment of patients with HCC who have been
PRACTICE GUIDELINE FOR THE Treatment of Patients With ...
www.psychiatryonline.orgTreatment of Patients With Eating Disorders 5 STATEMENT OF INTENT The American Psychiatric Association (APA) Practice Guidelines are not intended to be con-strued or to serve as a standard of medical care. Standards of medical care are determined on the basis of all clinical data available for an individual patient and are subject to change as sci-
HIGHLIGHTS OF PRESCRIBING INFORMATION
www.lenvima.comHepatocellular Carcinoma (HCC) • For the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC). (1.3) Endometrial Carcinoma (EC) • In combination with pembrolizumab, for the treatment of patients with advanced endometrial carcinoma (EC) that is not microsatellite
CLINICAL PRACTICE PTSD
www.apa.orgClinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults American Psychological Association Guideline Development Panel for the Treatment of PTSD in Adults Adopted as APA Policy February 24, 2017 GDP Members: Christine A. Courtois, Chair Jeffrey Sonis, Vice-Chair Laura S. Brown Joan Cook John A. Fairbank
CLINICAL PRACTICE PTSD - American Psychological …
www.apa.orgClinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults American Psychological Association Guideline Development Panel for the Treatment of …
NINLARO (ixazomib) capsules, for oral use Hepatotoxicity ...
www.ninlaro.comlenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. (1) -----DOSAGE AND ADMINISTRATION----- Recommended starting dose of 4 mg taken orally on Days 1, 8, and 15 of a 28-day cycle. (2.1) Dose should be taken at least one hour before or at least two hours after ...
BUPRENORPHINE (Trade Names: Buprenex®, Suboxone®, …
www.deadiversion.usdoj.govBuprenorphine is intended for the treatment of pain (Buprenex®) and opioid addiction (Suboxone® and Subutex®). In 2001, 2005, and 2006, the Narcotic Addict Treatment Act was amended to allow qualified physicians, under certification of the DHHS, to prescribe III-V narcotic drugs (FDA schedule
Buprenorphine Quick Start Guide - SAMHSA
www.samhsa.govoverdose if opioid use is resumed after tolerance is lost. Evaluate the need for medically managed withdrawal from opioids Those starting buprenorphine must be in a state of withdrawal. 9. Address co-occurring disorders: All medications for the treatment of the opioid use disorder may be prescribed as part of a. comprehensive individualized ...
Vancomycin-Resistant Enterococcus Treatment Guidance
www.med.unc.edu4Chuang YC, Wang JT, Lin HY, et al. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis. BMC Infect Dis 2014; 14: 687. 5Narayanan N, Rai R, Vaidya P, et al. Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia.
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euLENVIMA in combination with pembrolizumab is indicated for the treatment of adult patients with advanced or recurrent endometrial carcinoma (EC) who have disease progression on or following prior treatment with a platinum-containing therapy in any setting and are not candidates for curative surgery or radiation.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.ferringusa.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE LYSTEDA™ (tranexamic acid, USP) Tablets is indicated for the treatment of …
EPIDIOLEX (cannabidiol) oral solution
www.accessdata.fda.govEPIDIOLEX is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS) in patients 2 years of age and older. 2 DOSAGE AND ADMINISTRATION . 2.1 Assessments Prior to Initiating EPIDIOLEX . Because of the risk of hepatocellular injury, obtain serum transaminases (ALT and AST) and total bilirubin
MINDFULNESS AND ACCEPTANCE-BASED GROUP …
www.actonsocialanxiety.comuse of mindfulness and acceptance-based interventions for the treatment of SAD. Additionally, MAGT has been compared to cognitive behavioral group therapy (CBGT: Heimberg & Becker, 2002) and a wait list control group in a randomized controlled trial (Kocovski, Fleming, Hawley, & Antony, 2013). In that study, MAGT and CBGT were both found to be
TREATING BIPOLAR DISORDER - Beacon Health Options
www.valueoptions.comBased on Practice Guideline for the Treatment of Patients With Bipolar Disorder, Second Edition, originally published in April 2002. TREATING BIPOLAR DISORDER
Similar queries
Treatment, Opioid use, For the Treatment, Disorders, Guideline, Clinical, Clinical development of medicinal products intended for the treatment, Guidelines, Hepatocellular, Treatment of Patients With Eating Disorders, Hepatocellular carcinoma, Carcinoma, CLINICAL PRACTICE, Clinical Practice Guideline for the Treatment, American Psychological Association Guideline, CLINICAL PRACTICE PTSD, American Psychological, American Psychological Association, Multiple myeloma, Buprenorphine, Buprenorphine Quick Start Guide, Vancomycin, Versus linezolid, Linezolid, ANNEX I, PRESCRIBING INFORMATION, Tranexamic acid, Of hepatocellular, MINDFULNESS AND ACCEPTANCE-BASED GROUP, Based, Therapy, TREATING BIPOLAR DISORDER, Beacon Health Options